A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective study.
Sara LindhagenPontus KarlingPublished in: Scandinavian journal of gastroenterology (2021)
The shift towards a telemedicine oriented IBD healthcare service in the first year of the pandemic significantly increased the scheduled contacts, as well as the frequency of FC testing. However, there was a significant decrease in performed surveillance colonoscopies. Between the two periods observed, the patients showed no difference in medical treatment or in disease activity.
Keyphrases
- disease activity
- sars cov
- systemic lupus erythematosus
- rheumatoid arthritis
- healthcare
- rheumatoid arthritis patients
- ankylosing spondylitis
- coronavirus disease
- juvenile idiopathic arthritis
- patients with inflammatory bowel disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- respiratory syndrome coronavirus
- patient reported outcomes
- affordable care act